Anlotinib Suppresses Colorectal Cancer Proliferation and Angiogenesis via Inhibition of AKT/ERK Signaling Cascade

BACKGROUND: Anlotinib is a highly potent multi-target tyrosine kinase inhibitor, with very good anti-tumor activity against a variety of solid tumors. However, its effect on colorectal cancer (CRC) is not yet clearly understood. The objective of this study was to investigate the anti-tumor effect an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qian, Ni, Laichao, Imani, Saber, Xiang, Zhangqiang, Hai, Rui, Ding, Ruilin, Fu, Shaozhi, Wu, Jing bo, Wen, Qinglian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321688/
https://www.ncbi.nlm.nih.gov/pubmed/32606981
http://dx.doi.org/10.2147/CMAR.S252181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321688/
https://www.ncbi.nlm.nih.gov/pubmed/32606981
http://dx.doi.org/10.2147/CMAR.S252181

Ejemplares similares